Cargando…

Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak

BACKGROUND: The last ebola virus disease (EVD) outbreak has been the most important since 1976. EVD cases decreased drastically in Sierra Leone at the beginning of 2015. We aim to determine the clinical findings and evolution of patients admitted to an Ebola treatment center (ETC) during the epidemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arranz, Javier, Lundeby, Karen Marie, Hassan, Shoaib, Zabala Fuentes, Luis Matías, San José Garcés, Pedro, Haaskjold, Yngvar Lunde, Bolkan, Håkon Angell, Krogh, Kurt Østhuus, Jongopi, James, Mellesmo, Sindre, Jøsendal, Ola, Øpstad, Åsmund, Svensen, Erling, Kamara, Alfred Sandy, Roberts, David P., Stamper, Paul D., Austin, Paula, Moosa, Alfredo J., Marke, Dennis, Berg, Åse, Blomberg, Bjørn, Riera, Melcior
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916532/
https://www.ncbi.nlm.nih.gov/pubmed/27334891
http://dx.doi.org/10.1186/s12879-016-1609-9
_version_ 1782438845264953344
author Arranz, Javier
Lundeby, Karen Marie
Hassan, Shoaib
Zabala Fuentes, Luis Matías
San José Garcés, Pedro
Haaskjold, Yngvar Lunde
Bolkan, Håkon Angell
Krogh, Kurt Østhuus
Jongopi, James
Mellesmo, Sindre
Jøsendal, Ola
Øpstad, Åsmund
Svensen, Erling
Kamara, Alfred Sandy
Roberts, David P.
Stamper, Paul D.
Austin, Paula
Moosa, Alfredo J.
Marke, Dennis
Berg, Åse
Blomberg, Bjørn
Riera, Melcior
author_facet Arranz, Javier
Lundeby, Karen Marie
Hassan, Shoaib
Zabala Fuentes, Luis Matías
San José Garcés, Pedro
Haaskjold, Yngvar Lunde
Bolkan, Håkon Angell
Krogh, Kurt Østhuus
Jongopi, James
Mellesmo, Sindre
Jøsendal, Ola
Øpstad, Åsmund
Svensen, Erling
Kamara, Alfred Sandy
Roberts, David P.
Stamper, Paul D.
Austin, Paula
Moosa, Alfredo J.
Marke, Dennis
Berg, Åse
Blomberg, Bjørn
Riera, Melcior
author_sort Arranz, Javier
collection PubMed
description BACKGROUND: The last ebola virus disease (EVD) outbreak has been the most important since 1976. EVD cases decreased drastically in Sierra Leone at the beginning of 2015. We aim to determine the clinical findings and evolution of patients admitted to an Ebola treatment center (ETC) during the epidemic’s late phase. METHODS: We analyze retrospectively data of patients admitted to the Moyamba ETC (December 2014-March 2015). Patients were classified in EVD or non-EVD patients according to the results of Ebola virus real-time reverse transcription polymerase chain reaction (ZAIRE-RT-PCR). RESULTS: Seventy-five patients were included, 41.3 % were positive for ZAIRE-RT-PCR. More women (68 % vs 28 %, p = 0.001) were EVD-positive. More EVD patients had previous contact with an Ebola patient (74.2 % vs 36.3 %, p < 0.001). At admission, EVD patients were more likely to have fatigue (96.7 %, p < 0.001), diarrhea (67.7 %, p = 0.002), and muscle pain (61.3 %, p = 0.009); but only objective fevers in 35.5 % of EVD patients. The most reliable criteria for diagnosis were: contact with an Ebola patient plus three WHO symptoms (LR + =3.7, 95 % CI = 1.9–7.3), and positive contact (LR + =2.3, 95 % CI = 1.15–4.20). Only 45.2 % of EVD patients developed fevers during stay, but 75 % developed gastrointestinal symptoms. Non-EVD patients had gastrointestinal problems (33 %), respiratory conditions (26.6 %), and others such as malaria, HIV or tuberculosis with a mortality rate of 11.4 %. vs 58 % in EVD group (p < 0.001). CONCLUSIONS: More non-EVD patients were admitted in the outbreak’s late phases. The low percentage of initial fever highlights the need to emphasize the epidemiological information. EVD patients presented new symptoms getting worse and requiring closer follow-up. Diagnoses of non-EVD patients were diverse with a remarkable mortality, presenting a challenge for the health system.
format Online
Article
Text
id pubmed-4916532
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49165322016-06-27 Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak Arranz, Javier Lundeby, Karen Marie Hassan, Shoaib Zabala Fuentes, Luis Matías San José Garcés, Pedro Haaskjold, Yngvar Lunde Bolkan, Håkon Angell Krogh, Kurt Østhuus Jongopi, James Mellesmo, Sindre Jøsendal, Ola Øpstad, Åsmund Svensen, Erling Kamara, Alfred Sandy Roberts, David P. Stamper, Paul D. Austin, Paula Moosa, Alfredo J. Marke, Dennis Berg, Åse Blomberg, Bjørn Riera, Melcior BMC Infect Dis Research Article BACKGROUND: The last ebola virus disease (EVD) outbreak has been the most important since 1976. EVD cases decreased drastically in Sierra Leone at the beginning of 2015. We aim to determine the clinical findings and evolution of patients admitted to an Ebola treatment center (ETC) during the epidemic’s late phase. METHODS: We analyze retrospectively data of patients admitted to the Moyamba ETC (December 2014-March 2015). Patients were classified in EVD or non-EVD patients according to the results of Ebola virus real-time reverse transcription polymerase chain reaction (ZAIRE-RT-PCR). RESULTS: Seventy-five patients were included, 41.3 % were positive for ZAIRE-RT-PCR. More women (68 % vs 28 %, p = 0.001) were EVD-positive. More EVD patients had previous contact with an Ebola patient (74.2 % vs 36.3 %, p < 0.001). At admission, EVD patients were more likely to have fatigue (96.7 %, p < 0.001), diarrhea (67.7 %, p = 0.002), and muscle pain (61.3 %, p = 0.009); but only objective fevers in 35.5 % of EVD patients. The most reliable criteria for diagnosis were: contact with an Ebola patient plus three WHO symptoms (LR + =3.7, 95 % CI = 1.9–7.3), and positive contact (LR + =2.3, 95 % CI = 1.15–4.20). Only 45.2 % of EVD patients developed fevers during stay, but 75 % developed gastrointestinal symptoms. Non-EVD patients had gastrointestinal problems (33 %), respiratory conditions (26.6 %), and others such as malaria, HIV or tuberculosis with a mortality rate of 11.4 %. vs 58 % in EVD group (p < 0.001). CONCLUSIONS: More non-EVD patients were admitted in the outbreak’s late phases. The low percentage of initial fever highlights the need to emphasize the epidemiological information. EVD patients presented new symptoms getting worse and requiring closer follow-up. Diagnoses of non-EVD patients were diverse with a remarkable mortality, presenting a challenge for the health system. BioMed Central 2016-06-22 /pmc/articles/PMC4916532/ /pubmed/27334891 http://dx.doi.org/10.1186/s12879-016-1609-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Arranz, Javier
Lundeby, Karen Marie
Hassan, Shoaib
Zabala Fuentes, Luis Matías
San José Garcés, Pedro
Haaskjold, Yngvar Lunde
Bolkan, Håkon Angell
Krogh, Kurt Østhuus
Jongopi, James
Mellesmo, Sindre
Jøsendal, Ola
Øpstad, Åsmund
Svensen, Erling
Kamara, Alfred Sandy
Roberts, David P.
Stamper, Paul D.
Austin, Paula
Moosa, Alfredo J.
Marke, Dennis
Berg, Åse
Blomberg, Bjørn
Riera, Melcior
Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak
title Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak
title_full Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak
title_fullStr Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak
title_full_unstemmed Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak
title_short Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak
title_sort clinical features of suspected ebola cases referred to the moyamba etc, sierra leone: challenges in the later stages of the 2014 outbreak
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916532/
https://www.ncbi.nlm.nih.gov/pubmed/27334891
http://dx.doi.org/10.1186/s12879-016-1609-9
work_keys_str_mv AT arranzjavier clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT lundebykarenmarie clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT hassanshoaib clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT zabalafuentesluismatias clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT sanjosegarcespedro clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT haaskjoldyngvarlunde clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT bolkanhakonangell clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT kroghkurtøsthuus clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT jongopijames clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT mellesmosindre clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT jøsendalola clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT øpstadasmund clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT svensenerling clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT kamaraalfredsandy clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT robertsdavidp clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT stamperpauld clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT austinpaula clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT moosaalfredoj clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT markedennis clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT bergase clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT blombergbjørn clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak
AT rieramelcior clinicalfeaturesofsuspectedebolacasesreferredtothemoyambaetcsierraleonechallengesinthelaterstagesofthe2014outbreak